Growth is easy to defend in principle and hard to execute when capital, management attention, and integration capacity are constrained. Pursuing share, acquiring, affiliating, or rationalizing service lines only helps if those choices translate into better access and stronger economics. The discipline is distinguishing growth that strengthens the system from complexity that only consumes capital and attention.
This Session Will Examine:
- Screening growth options for whether they improve access and economics, or just add volume.
- M&A and affiliations after close: where integration stalls (governance, revenue cycle, clinical operating model) and how long value takes to arrive.
- Service-line decisions under constraint: which lines earn investment, which get consolidated across sites, and what exiting a service does to referral patterns and community standing.
- Demand changes that can unsettle specialty and surgical volume assumptions, starting with GLP-1s, bariatrics and the procedures tied to obesity-related disease, and the ambulatory shift.
- Competitive openings created by cyber events, access breakdowns, or operational distress: when a competitor's downtime shifts volume, and what it takes to absorb it without degrading your own access.